PTPN11 and glioma: This suggests that in the treatment of gliomas, developing targeted inhibitors against SHP2 or employing a treatment regimen that combines SHP2 inhibitors with other signaling pathway inhibitors and traditional chemotherapeutic drugs, is expected to bring more effective treatment strategies for glioma patients.